Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial

PaperCitations, authors & open-access status

Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 28 citations, 2024 year and closed oa status.

28
Citations
2024
Year
closed
OA Status

Related on ScholarIQ

Wenqing Wang
Author
Psoriasis: Treatment and Pathogenesis
Topic
Psoriasis: Treatment and Pathogenesis
Topic
Spondyloarthritis Studies and Treatments
Topic
Dermatology and Skin Diseases
Topic
470M+ articles · free account